Russotti Gregory 4

What Happened

• Gregory Russotti, Chief Technology and Manufacturing Officer at Century Therapeutics (IPSC), sold 479 shares on 2026-03-09 at $2.54 per share, totaling $1,215.
• The sale was not an open-market discretionary trade for investment purposes; it was an automatic sale to cover tax withholding related to vesting restricted stock units.

Key Details

• Transaction date and price: 2026-03-09 — 479 shares sold at $2.54 each.
• Total proceeds: $1,215.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The sale was to satisfy tax withholding obligations on vested RSUs; the sale was automatic and not at the reporting person’s discretion (footnote F1).
• Filing timeliness: Report filed 2026-03-11, within two business days of the transaction (timely).

Context

• Sales to cover tax withholding for vested restricted stock units are routine administrative transactions and do not necessarily signal the insider’s view on the company’s prospects.
• The relatively small dollar amount ($1.2K) underscores the administrative nature of the transaction rather than a material disposition.